CRVS

CRVS Other Income/Expenses (Net)

$3.54MTTM · USD

Period ending:

CRVS FY Other Income/Expenses (Net)USD
CRVS FY Other Income/Expenses (Net)2014-12-31: $0.002015-12-31: -$17.57M2016-12-31: $601.00K2017-12-31: $861.00K2018-12-31: $2.28M2019-12-31: $2.18M2020-12-31: $37.77M2021-12-31: -$4.61M2022-12-31: -$8.74M2023-12-31: -$3.62M2024-12-31: -$34.75M2025-12-31: $27.69M$37.77M-$34.75M
2014-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

CRVS other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 12 observations from Dec 31, 2014 to Dec 31, 2025.

Corvus Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
27,688,000
-34,745,000
-3,622,000
-8,742,000
-4,611,000
37,765,000
2,182,000
2,283,000
861,000
601,000
-17,565,000
0

Compare other income/expenses (net)

All CRVS financial metrics · CRVS stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.